Amneal reports second quarter 2021 financial results

Bridgewater, n.j.--(business wire)--amneal pharmaceuticals, inc. (nyse:amrx) (the “company”) announced its results today for the second quarter ended june 30, 2021. “our strong second quarter results reflect the durability and diversity of our business. at a time when drug prices are rising and more people are seeking affordable health care solutions, we are proud to consistently be first or second to market with new and complex generic drugs. together with our robust pipeline of specialty prod
AMRX Ratings Summary
AMRX Quant Ranking